Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?
COVID-19
corticosteroid therapy
interleukin-6
myeloperoxidase
neutrophil to lymphocyte ratio
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2021
2021
Historique:
received:
04
02
2021
accepted:
24
05
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
8
7
2021
Statut:
epublish
Résumé
COVID-19 may appear with a widely heterogeneous clinical expression. Thus, predictive markers of the outcome/progression are of paramount relevance. The neutrophil/lymphocyte ratio (NLR) has been suggested as a good predictive marker of disease severity and mortality. Accordingly, we found that NLR significantly increased in parallel with the WHO severity stage in COVID-19 patients during the I
Identifiants
pubmed: 34211953
doi: 10.3389/fpubh.2021.664108
pmc: PMC8239130
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
664108Informations de copyright
Copyright © 2021 Gelzo, Cacciapuoti, Pinchera, De Rosa, Cernera, Scialò, Mormile, Fabbrocini, Parrella, Gentile and Castaldo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
COPD. 2021 Feb;18(1):70-75
pubmed: 33302720
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Adv Respir Med. 2019;87(4):209-216
pubmed: 31476008
Nat Rev Immunol. 2020 Oct;20(10):587-588
pubmed: 32778829
Eur J Clin Invest. 2019 Jan;49(1):e13037
pubmed: 30316204
Am J Emerg Med. 2020 Mar;38(3):641-647
pubmed: 31785981
Front Immunol. 2018 Mar 13;9:302
pubmed: 29593707
Aging Clin Exp Res. 2021 Jan;33(1):193-199
pubmed: 33345291
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Clin Chem Lab Med. 2020 Jun 25;58(7):1162-1164
pubmed: 32333649
Expert Rev Gastroenterol Hepatol. 2018 May;12(5):503-513
pubmed: 29629626
J Infect Dis. 2021 May 20;223(9):1544-1554
pubmed: 33625513
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Dis Markers. 2020 Apr 27;2020:9731854
pubmed: 32454909
Clin Exp Med. 2019 Feb;19(1):37-45
pubmed: 30478648
Int J Mol Sci. 2018 Dec 17;19(12):
pubmed: 30563002
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Life Sci. 2020 Nov 15;261:118355
pubmed: 32871183
Crit Care. 2020 Nov 16;24(1):647
pubmed: 33198786